|
21GE
Solution structures of BRD9 bromodomain in complex with histone H3 acetyl-lysine 18 (H3K18ac) peptide
Deposited 2025-12-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
12–26(15 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.4;298 K;Ionic strength (raw mmCIF value) Null;Pressure 1
NMR sample composition
500 mM sodium chloride, 2.7 mM potassium chloride, 10 mM sodium phosphate, 1.8 mM potassium phosphate, 2 mM DTT, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
500 mM sodium chloride, 2.7 mM potassium chloride, 10 mM sodium phosphate, 1.8 mM potassium phosphate, 2 mM DTT, 100% D2O | 100% D2O
|
Resolution not provided
|
|
21HJ
Solution structures of BRD9 bromodomain in complex with histone H3 lactyl-lysine 18 (H3K18la) peptide
Deposited 2025-12-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
12–26(15 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.4;298 K;Ionic strength (raw mmCIF value) null;Pressure 1
NMR sample composition
500 mM sodium chloride, 2.7 mM potassium chloride, 10 mM sodium phosphate, 1.8 mM potassium phosphate, 2 mM DTT, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
500 mM sodium chloride, 2.7 mM potassium chloride, 10 mM sodium phosphate, 1.8 mM potassium phosphate, 2 mM DTT, 100% D2O | 100% D2O
|
Resolution not provided
|
|
3KV4
Structure of PHF8 in complex with histone H3
Deposited 2009-11-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
2–25(24 aa)
Fragment:UNP Residues 2-25
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ZN ZINC ION × 2
FE2 FE (II) ION × 1
NI NICKEL (II) ION × 1
EDO 1,2-ETHANEDIOL × 13
OGA N-OXALYLGLYCINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.6;25% (v/v) polyethylene glycol 3350, 0.2 M NaCl, and 0.1 M NaCitrate pH 5.6, VAPOR DIFFUSION, HANGING DROP
|
Resolution 2.19 Å
R-free 0.255
|
|
4Z5T
The nucleosome containing human H3.5
Deposited 2015-04-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 8
PDB declaration: decameric
|
Chain A
1–135(135 aa)
Chain E
1–135(135 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;potassium cacodylate, potassium chloride, manganese chloride
|
Resolution 2.80 Å
R-free 0.269
|
|
7W67
The crystal structure of MLL1 (N3861I/Q3867L/C3882SS)-RBBP5-ASH2L in complex with H3K4me0 peptide
Deposited 2021-12-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain M
2–10(9 aa)
|
Not recorded
|
SAH S-ADENOSYL-L-HOMOCYSTEINE × 1
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.2 M Sodium chloride, 0.1 M HEPES, pH 7.5, 25% w/v polyethylene glycol 3350
|
Resolution 2.19 Å
R-free 0.222
|
|
7W6I
The crystal structure of MLL1 (N3861I/Q3867L/C3882SS)-RBBP5-ASH2L in complex with H3K4me1 peptide
Deposited 2021-12-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
2–10(9 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
SAH S-ADENOSYL-L-HOMOCYSTEINE × 1
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.2 M Sodium chloride, 0.1 M HEPES, pH 7.5, 25% w/v polyethylene glycol 3,350
|
Resolution 2.56 Å
R-free 0.244
|
|
7W6J
The crystal structure of MLL1 (N3861I/Q3867L/C3882SS)-RBBP5-ASH2L in complex with H3K4me2 peptide
Deposited 2021-12-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
2–10(9 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
SAH S-ADENOSYL-L-HOMOCYSTEINE × 1
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;0.2 M Sodium chloride, 0.1 M HEPES, pH 7.5, 25% w/v polyethylene glycol 3350
|
Resolution 2.68 Å
R-free 0.252
|
|
7W6L
The crystal structure of MLL3-RBBP5-ASH2L in complex with H3K4me0 peptide
Deposited 2021-12-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain M
2–10(9 aa)
|
Not recorded
|
ZN ZINC ION × 2
SAH S-ADENOSYL-L-HOMOCYSTEINE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;100 mM sodium cacodylate, pH 6.5, 10% polyethylene glycol 3350, 0.1 M MgCl2
|
Resolution 2.26 Å
R-free 0.223
|
|
8Q1G
LSD1-CoREST bound to Acetylated K14 of Histone H3
Deposited 2023-07-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
2–22(21 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
FAD FLAVIN-ADENINE DINUCLEOTIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;Sodium Tartrate 1.2M, ADA 0.1M,
|
Resolution 2.60 Å
R-free 0.255
|
|
8Q1H
LSD1 Y391K-CoREST bound to Histone H3 N-terminal tail
Deposited 2023-07-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
2–22(21 aa)
|
Not recorded
|
FAD FLAVIN-ADENINE DINUCLEOTIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;Sodium Tartrate 1.2 M, ADA 0.1M
|
Resolution 2.90 Å
R-free 0.254
|
|
8Q1J
LSD1 Y391K-CoREST bound to Acetylated K14 of Histone H3
Deposited 2023-07-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
2–22(21 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
FAD FLAVIN-ADENINE DINUCLEOTIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;Sodium Tartate 1.2 M, ADA 0.1M
|
Resolution 2.87 Å
R-free 0.272
|
|
8RBX
Structure of Integrator-PP2A bound to a paused RNA polymerase II-DSIF-NELF-nucleosome complex
Deposited 2023-12-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 43
PDB declaration: 46-meric
|
Chain M
1–135(135 aa)
Chain S
1–135(135 aa)
|
Not recorded
|
ZN ZINC ION × 10
MG MAGNESIUM ION × 1
MN MANGANESE (II) ION × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.10 Å
|
|
8T4F
Transporter associated with antigen processing (TAP) bound to the 9-mer peptide RRYQKSTEL
Deposited 2023-06-09
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
52–60(9 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 6.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.50 Å
|
|
8VLD
Crystal structure of Ash1L PHD finger in complex with histone H3K4me2
Deposited 2024-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain P
2–12(11 aa)
Chain T
2–12(11 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;1.6 M sodium citrate pH 6.5
|
Resolution 1.92 Å
R-free 0.249
|
|
8VLF
Crystal structure of Ash1L PHD finger in complex with histone H3K4me3
Deposited 2024-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain P
2–13(12 aa)
Chain T
2–13(12 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;1.6 M sodium citrate pH 6.5
|
Resolution 1.34 Å
R-free 0.188
|
|
8Z73
Crystal Structure of AF9 in complex with H3K9la peptide
Deposited 2024-04-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain P
2–11(10 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;2.4M Sodium Malonate
|
Resolution 2.91 Å
R-free 0.221
|
|
8Z73
Crystal Structure of AF9 in complex with H3K9la peptide
Deposited 2024-04-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
2–11(10 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;2.4M Sodium Malonate
|
Resolution 2.91 Å
R-free 0.221
|
|
8Z73
Crystal Structure of AF9 in complex with H3K9la peptide
Deposited 2024-04-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
2–11(10 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;2.4M Sodium Malonate
|
Resolution 2.91 Å
R-free 0.221
|
|
8Z73
Crystal Structure of AF9 in complex with H3K9la peptide
Deposited 2024-04-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain G
2–11(10 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;2.4M Sodium Malonate
|
Resolution 2.91 Å
R-free 0.221
|
|
8ZXC
NMR solution structures of ASH1L BRD-PHD domain in complex with H3K4me2 peptide
Deposited 2024-06-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
2–13(12 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ZN ZINC ION × 2
|
SOLUTION NMR
NMR measurement conditions
pH 7.5;298 K;Ionic strength (raw mmCIF value) null;Pressure 1
NMR sample composition
100 mM sodium phosphate, 2 mM DTT, 50 mM potassium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
100 mM sodium phosphate, 2 mM DTT, 50 mM potassium chloride, 100% D2O | 100% D2O
|
Resolution not provided
|
|
9C0O
Crystal structure of DmCfp1 PHD finger bound to H3K4me3
Deposited 2024-05-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
2–16(15 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
DMS DIMETHYL SULFOXIDE × 1
ZN ZINC ION × 3
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;15% PEG3350, 0.01M Tris pH8.5, 0.2M Ammonium sulfate
|
Resolution 1.53 Å
R-free 0.194
|
|
9DZN
KAT6A MYST domain complexed with a H3K14-CoA bisubstrate inhibitor
Deposited 2024-10-16
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
6–24(19 aa)
|
Not recorded
|
CMC CARBOXYMETHYL COENZYME *A × 1
ZN ZINC ION × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;294.15 K;1.25 M NH4SO4, 0.28 M NaCl, and 0.1 M HEPES pH 6.4
|
Resolution 1.72 Å
R-free 0.245
|
|
9IM4
Crystal Structure of AF9 YEATS domain F28R mutant in complex with histone H3K9la
Deposited 2024-07-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain P
2–11(10 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;2.1M DL Malic acid pH7.0
|
Resolution 2.79 Å
R-free 0.315
|
|
9IM4
Crystal Structure of AF9 YEATS domain F28R mutant in complex with histone H3K9la
Deposited 2024-07-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
2–11(10 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;2.1M DL Malic acid pH7.0
|
Resolution 2.79 Å
R-free 0.315
|
|
9N61
Transporter associated with antigen processing (TAP) bound to the 9-mer peptide RRYQKSTEL and ATP
Deposited 2025-02-04
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
52–60(9 aa)
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 6.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.60 Å
|
|
9V5M
The crystal structure of RBBP4-H3 complex
Deposited 2025-05-26
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
2–15(14 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.10 Å
R-free 0.211
|